CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
A key cause of both stroke and dementia is known as ‘small vessel disease’ or ‘SVD’ for short.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
If you are worried about vascular dementia, this guide is for you. It provides information about the signs of vascular dementia, living with the condition, and getting help and support.
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.
If you are of African or Caribbean origin you may have a higher risk of stroke than other people in the UK due to health conditions such as high blood presure, diabetes and sickle cell disease. This guide explains more about your risk of a stroke, and what you can do to reduce your risk.
Around 85% of strokes are due to a blocked blood vessel in the brain, known as an ischaemic stroke. This guide explains what an ischaemic stroke is, what can cause you to have one, and how it is usually diagnosed and treated.
Stroke is the biggest cause of complex disability worldwide, with an estimated 1.2 million stroke survivors in the UK today. Living with the long term impact of the condition can be devastating, yet this new report suggests that research funding dedicated to stroke remains disproportionately small compared to other diseases.
Our annual Keynote Lecture showcases some of the latest advancements being made in stroke research.
This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester. Professor Rothwell is one of the UK’s leading neuroscientists whose research focuses on inflammation in brain disease, especially stroke.